Literature DB >> 8455045

Selection to postmenopausal therapy by women's characteristics.

E Hemminki1, M Malin, P Topo.   

Abstract

Many surveys have shown that women using postmenopausal hormone therapy have a lower incidence of cardiovascular diseases and lower overall mortality. The purpose of this study was to compare past and non-users with current users of hormone therapy in regard to characteristics known to, or assumed to, predict poor subsequent health (indicators). The main data source was a survey in 1989 of a random sample (n = 2000, 86% response rate) of 45-64 year-old Finnish women. Among women with their uterus, after adjusting for age and urbanism, of the 21 indicators studied, 10 suggested a poorer and none a better health prognosis for the non-users than for current users. Many differences were greater among older women, suggesting a cohort effect or long-term users being an especially selected group. Among hysterectomized women, differences between users and non-users were similar or smaller than among women with uteri. The past users were more similar to non-users than current users. Our study suggests that women with a better health prognosis are selected or select themselves for hormone therapy, and that may impede interpretation of observational studies on hormone therapy and health.

Entities:  

Mesh:

Year:  1993        PMID: 8455045     DOI: 10.1016/0895-4356(93)90068-c

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  11 in total

Review 1.  Synthesising licensing data to assess drug safety.

Authors:  Klim McPherson; Elina Hemminki
Journal:  BMJ       Date:  2004-02-28

2.  Hormone replacement therapy: knowledge, attitudes, and well-being among middle-aged Australian women.

Authors:  K France; C Lee; M Schofield
Journal:  Int J Behav Med       Date:  1996

Review 3.  [Estrogens for prevention of coronary heart disease?].

Authors:  T Meinertz
Journal:  Herz       Date:  1997-06       Impact factor: 1.443

4.  Characteristics of women currently using hormone replacement therapy in rural areas of Styria, Austria.

Authors:  E Rásky; W Freidl; W J Stronegger; C Scheuringer
Journal:  Soz Praventivmed       Date:  1997

5.  Ovarian aging and hormone replacement therapy. Hormonal levels, symptoms, and attitudes of African-American and white women.

Authors:  K T Pham; J A Grisso; E W Freeman
Journal:  J Gen Intern Med       Date:  1997-04       Impact factor: 5.128

6.  Health status of users of hormone replacement therapy by hysterectomy status in Western Australia.

Authors:  L J Lambert; J A Y Straton; M W Knuiman; H C Bartholomew
Journal:  J Epidemiol Community Health       Date:  2003-04       Impact factor: 3.710

7.  Oral health in perimenopausal and early postmenopausal women from baseline to 2 years of follow-up with reference to hormone replacement therapy.

Authors:  L Tarkkila; J Furuholm; A Tiitinen; J H Meurman
Journal:  Clin Oral Investig       Date:  2008-02-26       Impact factor: 3.573

8.  Frontiers proposal. National Institute on Aging "bench to bedside: estrogen as a case study".

Authors:  Sanjay Asthana; Roberta Diaz Brinton; Victor W Henderson; Bruce S McEwen; John H Morrison; Peter J Schmidt
Journal:  Age (Dordr)       Date:  2009-03-10

9.  Three midlife strategies to prevent cognitive impairment due to Alzheimer's disease.

Authors:  V W Henderson
Journal:  Climacteric       Date:  2014-08-17       Impact factor: 3.005

Review 10.  Educating patients about the benefits and drawbacks of hormone replacement therapy.

Authors:  S Rozenberg; J B Vasquez; J Vandromme; M Kroll
Journal:  Drugs Aging       Date:  1998-07       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.